InfuSystem to be Acquired for $1.1 Billion
Ticker: INFU · Form: 8-K · Filed: Jun 12, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: acquisition, private-equity, merger
TL;DR
Patient Square Capital buying InfuSystem for $1.1B ($13/share) - deal expected Q3.
AI Summary
InfuSystem Holdings, Inc. announced on June 12, 2024, that it has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital. The transaction is valued at approximately $1.1 billion, representing $13.00 per share in cash. The deal is expected to close in the third quarter of 2024, subject to customary closing conditions.
Why It Matters
This acquisition by Patient Square Capital at a significant premium indicates strong investor confidence in InfuSystem's future prospects and could lead to substantial returns for current shareholders.
Risk Assessment
Risk Level: low — The acquisition is at a premium and has a definitive agreement, suggesting a high likelihood of completion.
Key Numbers
- $1.1B — Transaction Value (Total amount Patient Square Capital is paying for InfuSystem.)
- $13.00 — Price Per Share (Cash amount shareholders will receive for each share.)
- Q3 2024 — Expected Closing (Anticipated timeframe for the acquisition to be finalized.)
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Company being acquired
- Patient Square Capital (company) — Acquiring entity
- $1.1 billion (dollar_amount) — Total transaction value
- $13.00 (dollar_amount) — Price per share
- June 12, 2024 (date) — Date of announcement
- third quarter of 2024 (date) — Expected closing period
FAQ
Who is acquiring InfuSystem Holdings, Inc.?
An affiliate of Patient Square Capital is acquiring InfuSystem Holdings, Inc.
What is the total value of the acquisition?
The total value of the acquisition is approximately $1.1 billion.
What is the price per share being offered?
The price per share being offered is $13.00 in cash.
When is the acquisition expected to close?
The acquisition is expected to close in the third quarter of 2024.
What conditions must be met for the deal to close?
The deal is subject to customary closing conditions.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-06-12 16:39:12
Filing Documents
- infu-20240612.htm (8-K) — 27KB
- exhibit9911q24investorpr.htm (EX-99.1) — 27KB
- exhibit9911q24investorpr001.jpg (GRAPHIC) — 92KB
- exhibit9911q24investorpr002.jpg (GRAPHIC) — 200KB
- exhibit9911q24investorpr003.jpg (GRAPHIC) — 107KB
- exhibit9911q24investorpr004.jpg (GRAPHIC) — 111KB
- exhibit9911q24investorpr005.jpg (GRAPHIC) — 126KB
- exhibit9911q24investorpr006.jpg (GRAPHIC) — 94KB
- exhibit9911q24investorpr007.jpg (GRAPHIC) — 115KB
- exhibit9911q24investorpr008.jpg (GRAPHIC) — 94KB
- exhibit9911q24investorpr009.jpg (GRAPHIC) — 101KB
- exhibit9911q24investorpr010.jpg (GRAPHIC) — 99KB
- exhibit9911q24investorpr011.jpg (GRAPHIC) — 103KB
- exhibit9911q24investorpr012.jpg (GRAPHIC) — 116KB
- exhibit9911q24investorpr013.jpg (GRAPHIC) — 84KB
- exhibit9911q24investorpr014.jpg (GRAPHIC) — 99KB
- exhibit9911q24investorpr015.jpg (GRAPHIC) — 92KB
- exhibit9911q24investorpr016.jpg (GRAPHIC) — 85KB
- exhibit9911q24investorpr017.jpg (GRAPHIC) — 88KB
- exhibit9911q24investorpr018.jpg (GRAPHIC) — 89KB
- exhibit9911q24investorpr019.jpg (GRAPHIC) — 81KB
- exhibit9911q24investorpr020.jpg (GRAPHIC) — 55KB
- exhibit9911q24investorpr021.jpg (GRAPHIC) — 96KB
- exhibit9911q24investorpr022.jpg (GRAPHIC) — 127KB
- 0001628280-24-027849.txt ( ) — 3290KB
- infu-20240612.xsd (EX-101.SCH) — 2KB
- infu-20240612_lab.xml (EX-101.LAB) — 21KB
- infu-20240612_pre.xml (EX-101.PRE) — 12KB
- infu-20240612_htm.xml (XML) — 3KB
01 - Regulation FD Disclosure
Item 7.01 - Regulation FD Disclosure InfuSystem Holdings, Inc. (the "Company") hereby furnishes the information set forth in the Investor Presentation dated June 12, 2024, which is attached hereto as Exhibit 99.1. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the Investor Presentation attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 InfuSystem Holdings, Inc. Investor Presentation dated June 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: June 12, 2024